SLNP-based CDK4- targeted nanotherapy against glioblastoma.

Ghani U, Ghori FK, Qamar MU, Khan H, Azad B, Habib S, Justin S, Khan IN, Shah TA, Shazly GA, Bourhia M, Perveen F, Javed A

Open source

DOI
10.3389/fonc.2024.1455816
Published
2024
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2024.1455816,
  title = {SLNP-based CDK4- targeted nanotherapy against glioblastoma.},
  author = {Ghani U and Ghori FK and Qamar MU and Khan H and Azad B and Habib S and Justin S and Khan IN and Shah TA and Shazly GA and Bourhia M and Perveen F and Javed A},
  year = {2024},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2024.1455816},
  url = {https://doi.org/10.3389/fonc.2024.1455816}
}

RIS

TY  - JOUR
TI  - SLNP-based CDK4- targeted nanotherapy against glioblastoma.
AU  - Ghani U
AU  - Ghori FK
AU  - Qamar MU
AU  - Khan H
AU  - Azad B
AU  - Habib S
AU  - Justin S
AU  - Khan IN
AU  - Shah TA
AU  - Shazly GA
AU  - Bourhia M
AU  - Perveen F
AU  - Javed A
PY  - 2024
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2024.1455816
UR  - https://doi.org/10.3389/fonc.2024.1455816
ER  - 

APA

U, G., FK, G., MU, Q., H, K., B, A., S, H., S, J., IN, K., TA, S., GA, S., M, B., F, P., & A, J. (2024). SLNP-based CDK4- targeted nanotherapy against glioblastoma.. Frontiers in oncology. https://doi.org/10.3389/fonc.2024.1455816

Source records